Metagenomi Therapeutics Inc
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Metagenomi Therapeutics Inc
Metagenomi Therapeutics Inc is an vivo genome editing company capitalizing on its proprietary technologies to create curative genetic medicines for patients. The company leverages machine learning and artificial intelligence to enhance its signature gene editing systems. MGX-001 is its, wholly-owned development program in hemophilia A, where the company have demonstrated targeted genome editing and durable gene expression from a one-time treatment in non-human primates (NHPs) and an overall profile potentially competitive with best-in-class treatment options. MGX-001 is designed to provide curative, life-long protection from bleeding events and joint damage in adults and children with hemophilia A from a single administration.
/ 
Frequently asked questions
To buy Metagenomi Therapeutics Inc stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Metagenomi Therapeutics Inc by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Metagenomi Therapeutics Inc is MGX:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Metagenomi Therapeutics Inc has its primary listing on NASDAQ. You can trade Metagenomi Therapeutics Inc with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Metagenomi Therapeutics Inc is available to trade on SaxoInvestor and SaxoTrader. You can buy shares directly and include Metagenomi Therapeutics Inc as part of a broader investment portfolio.
Learn more about investing and trading in Saxo's education hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures—so you can make more informed decisions when considering shares like Metagenomi Therapeutics Inc or others.